KRYS Sale Disclosure
Krishnan Krish S · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$208.2K
Krishnan Krish S President And CEO
KRYS
Krystal Biotech
KRYS
Transaction date
Sep 4, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed same day
KRYS daily price context
Close on/before transaction
$358.24
Sep 4, 2026
Close before public filing
$371.47
Sep 3, 2026
Return since public filing
-10.46%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 573 shares @ $363.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001298709-26-000011
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$8.98M
Buys / sales
0 / 13
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Krystal Biotech, Inc. KRYS Current | Sale | Sep 4, 2026 | $208.2K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $184.36K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.42M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.21M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $721.46K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $728.93K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $816.81K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.17M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.13M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $438.99K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $494.96K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $309.51K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $148.46K |